Blood pressure regulation in ANF-transgenic mice: Role of angiotensin and vasopressin

B. Lichardus, A. T. Veress, L. J. Field, H. Sonnenberg

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Transgenic mice overexpressing a transthyretin promoter-ANF structural fusion gene have a life-long reduction in arterial blood pressure compered to nontransgenic littermates. The present study was designed to test the hypothesis that the high plasma level of ANF in the transgenic mice inhibits the renin-angiotensin and/or vasopressin systems, thereby causing the hypotension. Mice were anaesthetized with Inactin and arterial pressure and heart rate were monitored before and during Saralasin infusion and vasopressin V1 receptor blockade. Effectiveness of the blockade was determined by injection of angiotensin and vasopressin before and during Saralasin and V1 receptor antagonist administration. Saralasin was associated with hypotension in both transgenic and nontransgenic mice. The decrease in blood pressure was proportionally greater in the transgenic animals. Vasopressin receptor blockade had little effect on blood pressure in either group. Heart rates were not different between the groups during any maneuver. We conclude that the chronic hypotensive effect of ANF overproduction does not involve the inhibition of either renin-angiotensin or vasopressin systems. The data, however, suggest that the renin-angiotensin system may be stimulated in the ANF-transgenic mice.

Original languageEnglish (US)
Pages (from-to)145-150
Number of pages6
JournalPhysiological Research
Issue number3
StatePublished - Jan 1 1994
Externally publishedYes


  • atrial natriuretic factor
  • heart rate
  • hypotension
  • saralasin
  • vasopressin V receptor antagonist

ASJC Scopus subject areas

  • Physiology

Fingerprint Dive into the research topics of 'Blood pressure regulation in ANF-transgenic mice: Role of angiotensin and vasopressin'. Together they form a unique fingerprint.

Cite this